[144] HUBSPOT INC SEC Filing
Rhea-AI Filing Summary
HubSpot (HUBS) Form 144 notice shows a proposed sale of 8,500 common shares to be executed through Fidelity Brokerage Services on 09/16/2025 on the NYSE. The filing reports the seller as Brian P. Halligan and lists the aggregate market value of the proposed sale as $4,305,420. The issuer's total shares outstanding are reported as 52,693,110, providing context for the size of the sale relative to the company's equity base. The filing also discloses prior sales by the same person: three transactions of 8,500 shares each on 06/17/2025, 07/15/2025 and 08/19/2025 with gross proceeds shown for each sale.
Positive
- Rule 144 compliance: The filing provides the required notice and attestation, indicating procedural adherence to disclosure rules
- Transparency on prior sales: Records of three prior 8,500-share sales with gross proceeds are disclosed
Negative
- Repeated insider sales: The seller conducted at least three 8,500-share sales in June, July and August 2025 and proposes another on 09/16/2025, which may concern some investors
- Limited context: The filing contains no explanation for the sales or information on remaining insider holdings
Insights
TL;DR: Insider has executed multiple 8,500-share sales; current notice proposes another 8,500-share sale on 09/16/2025.
The filing documents routine Rule 144 compliance by an insider, identifying the seller as Brian P. Halligan and a proposed 8,500-share sale valued at $4,305,420 executed through Fidelity on the NYSE. The report includes three prior 8,500-share sales in June, July and August 2025 with disclosed gross proceeds. The issuer’s shares outstanding (52,693,110) allow investors to gauge the relative scale—a single 8,500-share sale is a small fraction of total equity. The filing contains no earnings, forward guidance, or material corporate events.
TL;DR: Filing reflects standard disclosure and attestation under Rule 144, including representation about material nonpublic information.
The notice includes the required attestation that the selling person does not possess undisclosed material adverse information and references Rule 10b5-1 procedural language. Dates of acquisition for the reported shares are provided (founders’ shares from 10/15/2014 and option grant dates), and payment/nature of acquisition is noted. No governance actions, officer resignations, or transaction motivations are stated.